Cargando…

Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer

Discovering novel biomarkers that easily accessed is a key step towards the personalized medicine approach for gastric cancer patients. Integrin-β6 (ITGB6) is a subtype of integrin that is exclusively expressed on the surface of epithelial cells and is up-regulated in various tumors. In the present...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zequn, Sun, Yuqi, Xu, Jianfei, Yang, Hao, Liu, Xiaodong, Tian, Yulong, Cao, Shougen, Zhou, Yanbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593195/ https://www.ncbi.nlm.nih.gov/pubmed/34796117 http://dx.doi.org/10.3389/fonc.2021.770997

Ejemplares similares

A novel prognostic factor TIPE2 inhibits cell proliferation and promotes apoptosis in pancreatic ductal adenocarcinoma (PDAC)
por: Sun, Yuqi, et al.
Publicado: (2021)

TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer
por: Li, Zequn, et al.
Publicado: (2022)

Concordance Between Watson for Oncology and a Multidisciplinary Clinical Decision-Making Team for Gastric Cancer and the Prognostic Implications: Retrospective Study
por: Tian, Yulong, et al.
Publicado: (2020)

Development and validation of nomograms for predicting overall survival and cancer-specific survival in elderly patients with locally advanced gastric cancer: a population-based study
por: Sun, Yuqi, et al.
Publicado: (2023)

A Nomogram for Prediction of Survival in Patients After Gastrectomy Within Enhanced Recovery After Surgery (ERAS): A Single-Center Retrospective Study
por: Sun, Yuqi, et al.
Publicado: (2020)

Intraoperative performance and outcomes of robotic and laparoscopic total gastrectomy for gastric cancer: A high‐volume center retrospective propensity score matching study
por: Jia, Zhuoyu, et al.
Publicado: (2023)

Could gut microbiota serve as prognostic biomarker associated with colorectal cancer patients' survival? A pilot study on relevant mechanism
por: Wei, Zhiliang, et al.
Publicado: (2016)

Integrin β6 serves as an immunohistochemical marker for lymph node metastasis and promotes cell invasiveness in cholangiocarcinoma
por: Li, Zequn, et al.
Publicado: (2016)

Alterations of Serum Uric Acid Level and Gut Microbiota After Roux-en-Y Gastric Bypass and Sleeve Gastrectomy in a Hyperuricemic Rat Model
por: Lu, Cunlong, et al.
Publicado: (2020)

Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response
por: Tian, Xi, et al.
Publicado: (2022)

Inflammation-related parameter serve as prognostic biomarker in esophageal squamous cell carcinoma
por: Xu, Xiaoqin, et al.
Publicado: (2022)

FN1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancers
por: Wang, Han, et al.
Publicado: (2022)

β(6)-Integrin Serves as a Potential Serum Marker for Diagnosis and Prognosis of Pancreatic Adenocarcinoma
por: Lenggenhager, Daniela, et al.
Publicado: (2021)

Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma
por: Zhang, Lu-yang, et al.
Publicado: (2019)

The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Zhang, Huaru, et al.
Publicado: (2021)

SRSF3 Expression Serves as a Potential Biomarker for Prognostic and Immune Response in Pan-Cancer
por: Li, Zihua, et al.
Publicado: (2022)

Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer
por: Gan, Xuejun, et al.
Publicado: (2023)

MECOM/PRDM3 and PRDM16 Serve as Prognostic-Related Biomarkers and Are Correlated With Immune Cell Infiltration in Lung Adenocarcinoma
por: Li, Meng, et al.
Publicado: (2022)

Circular RNA hsa_circ_0007507 May Serve as a Biomarker for the Diagnosis and Prognosis of Gastric Cancer
por: Zhang, Weiwei, et al.
Publicado: (2021)

ASRGL1 Correlates With Immune Cell Infiltration in Hepatocellular Carcinoma and Can Serve as a Prognostic Biomarker
por: Xue, Cailin, et al.
Publicado: (2021)

ITGA3 Is Associated With Immune Cell Infiltration and Serves as a Favorable Prognostic Biomarker for Breast Cancer
por: Li, Yue, et al.
Publicado: (2021)

Multimodal prehabilitation to improve the clinical outcomes of frail elderly patients with gastric cancer: a study protocol for a multicentre randomised controlled trial (GISSG(+)2201)
por: Sun, Yuqi, et al.
Publicado: (2023)

Identification of Therapeutic Targets and Prognostic Biomarkers Among Integrin Subunits in the Skin Cutaneous Melanoma Microenvironment
por: Nurzat, Yeltai, et al.
Publicado: (2021)

Integrin Alpha-2 as a Potential Prognostic and Predictive Biomarker for Patients With Lower-Grade Glioma
por: Lin, Li, et al.
Publicado: (2021)

Cancer-Testis Antigen LDH-C4 in Tissue, Serum, and Serum-Derived Exosomes Serves as a Promising Biomarker in Lung Adenocarcinoma
por: Peng, Wei, et al.
Publicado: (2022)

A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis
por: Li, Rongkang, et al.
Publicado: (2023)

E2F2/5/8 Serve as Potential Prognostic Biomarkers and Targets for Human Ovarian Cancer
por: Zhou, Quan, et al.
Publicado: (2019)

Extra Spindle Pole Bodies-Like 1 Serves as a Prognostic Biomarker and Promotes Lung Adenocarcinoma Metastasis
por: Nie, Zhi, et al.
Publicado: (2022)

B7H6 Serves as a Negative Prognostic Marker and an Immune Modulator in Human Pancreatic Cancer
por: Zhu, Zheng, et al.
Publicado: (2022)

High Levels of Cartilage Oligomeric Matrix Protein in the Serum of Breast Cancer Patients Can Serve as an Independent Prognostic Marker
por: Papadakos, Konstantinos S., et al.
Publicado: (2019)

A novel prognostic model based on three integrin subunit genes-related signature for bladder cancer
por: Tu, Hongtao, et al.
Publicado: (2022)

Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence
por: Zhou, Cen, et al.
Publicado: (2019)

TIPE2 acts as a biomarker for GIST risk category and suppresses the viability and invasiveness of GIST cells
por: Li, Zequn, et al.
Publicado: (2018)

Dysregulation of TLR2 Serves as a Prognostic Biomarker in Breast Cancer and Predicts Resistance to Endocrine Therapy in the Luminal B Subtype
por: Wang, Yunmei, et al.
Publicado: (2020)

TEADs serve as potential prognostic biomarkers and targets for human gastric cancer
por: Wang, Meng-huan, et al.
Publicado: (2022)

Serum Nitric Oxide Level Serves as a Potential Prognostic Biomarker in ACLF Patients
por: Wang, Fei, et al.
Publicado: (2022)

Integrin αvβ8 serves as a Novel Marker of Poor Prognosis in Colon Carcinoma and Regulates Cell Invasiveness through the Activation of TGF-β1
por: Zhou, Mingliang, et al.
Publicado: (2020)

Glycosylated Cathepsin V Serves as a Prognostic Marker in Lung Cancer
por: Yang, Lewei, et al.
Publicado: (2022)

LASTR is a novel prognostic biomarker and predicts response to cancer immunotherapy in gastric cancer
por: Liu, Jun-Yan, et al.
Publicado: (2022)

The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma
por: Zhu, Jinchao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_g97sm8q3gtpqovc178p00n3v75